Angioplasty Surgery Heart
The Indian arm MicroPort Scientific India Pvt. Ltd., a wholly owned subsidiary of MPSC, is aimed to serve the Indian patients with high-quality and yet affordable medical solutions to save, reshape and improve quality of their life. Making its Indian debut in early 2017 with a sturdy determination to always keep Indian patients first, MicroPort has made tremendous leaps forward in the Indian market in terms of market share and success stories.
With its products currently approved for use in over 5,000 hospitals in 80 countries worldwide, MicroPort™ Scientific is contributing to a better world through its life-saving medical therapies and quality-improving care devices being used in patients every 15 seconds. Paving way for more achievements and under its ambitious global expansion program, Microport has acquired OrthoRecon business of Wright Medical, USA and has made a strategic investment in Lombard Medical of U.K.
A Patient Oriented Global Enterprise
MicroPort Scientific Corporation can trace its origin back to 1998 to a small office at ZJ Hi-Tech Park, Shanghai China where a group of dedicated individuals joined together with a common belief that advancements in medical technology could transform and enhance the patients’ well-being not just in China but globally. During the past decades, the pioneers of MicroPort™ have devoted themselves to this mission of advancing the forefront of technology innovation to develop the best and most affordable medical therapies to treat patients around the globe.
Through years of growth and innovation, MicroPort™ has become a premier medical solution provider covering 10 major medical disciplines including interventional cardiology, orthopedics, interventional radiology, electrophysiology, diabetes and endocrine management, surgical management, and others. With over 200 products currently approved for use in over 5,000 hospitals worldwide, MicroPort™ is contributing to a better world through its life-saving medical therapies and quality-improving care devices being used in patients every 15 seconds.
With a large global footprint of R&D and manufacturing facilities (Shanghai, Jiangsu, Zhejiang, Beijing, Shenzhen in China, and Memphis, TN in the United States), a strong focus on technology innovation with over 1,600 issued patents, and a global workforce of over 3,000 employees, MicroPort™ is committed to its vision of being a patient oriented company capable of leading the future of minimally invasive healthcare and other emerging technologies.